Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh
Completed · Phase 3
Conditions studied: Vitamin A Deficiency, Maternal Mortality, Infant Mortality
In brief
The purpose of this trial is to determine whether providing women with a weekly oral supplement of vitamin A, either preformed or as beta-carotene, at a dosage equivalent to a recommended intake from early pregnancy through three months postpartum, can reduce the risk of maternal mortality, fetal loss, or infant mortality.
Key facts
- Study ID
- NCT00198822
- Run by
- Johns Hopkins Bloomberg School of Public Health
- People needed
- 59666
- Starts
- 2001-08-01
- Expected to finish
- 2008-03-01
- Last updated by the study team
- 2012-03-07
Who can join
Age: 15 and older, up to 49. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Married women of reproductive age
- First pregnancy during time period of trial
You may not qualify if…
- Premenarchial girls
- Married women with a previous pregnancy enrolled into the trial
- Previously married women who have moved into the study area
- Single women (never married, widowers)
- Women who are sterilized (or whose husbands are sterilized)
- Menopausal women
Where it is running
- Johns Hopkins School of Public Health — Baltimore, Maryland, United States
- JiVitA Bangladesh Project — Rangpur, Rajshahi Division, Bangladesh
- JiVitA Project Office — Rangpur City, Rangpur District, Bangladesh
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.